Speaker:

Eva Galanis, M.D. Consultant, Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota | Professor of Oncology, Mayo Clinic College of Medicine and Science | Full Faculty Privileges in Virology & Gene Therapy, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic College of Medicine and Science | Consultant (Joint Appointment), Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota | Chair, Department of Molecular Medicine, Mayo Clinic, Rochester, MinnesotaTitle

Objectives: 

• Discuss the mechanism of action of oncolytic viruses
• Review principles of bench to bedside translation of oncolytic viruses
• Discuss recent advances and future directions in the field on oncolytic virotherapy and immunovirotherapy

MMI Presentation: 

Curtis Lacy, M.D., Internal Medicine 

Locations:    

• Mayo Clinic Building, Taylor Auditorium
• Mayo Clinic Hospital, MCH Waugh Auditorium Side A (MCH 1-220A)
• Mayo Clinic Women’s Health Internal Medicine
• Mayo Clinic Family Medicine – Arrowhead
• Kingman Regional Medical Center
• Canyon Ranch Medical Center

ALL PHYSICIANS AND ALLIED STAFF ARE WELCOME

ATTENDANCE REQUIREMENT 
A unique presentation code must be sent via text to 507-200-3010 
to record attendance and to ensure you receive CME credit for your attendance.  
NOTE:  Attendees must be present to receive code.  

FACULTY DISCLOSURE

As a provider accredited by Accreditation Council on Continuing Medical Education (ACCME), Mayo Clinic College of Medicine and Science, must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships is included course materials so participants may formulate their own judgments regarding the presentation.